Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model
- 1 November 1995
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 22 (11) , 1249-1255
- https://doi.org/10.1007/bf00801608
Abstract
In the present study, radioiodinated human recombinant interleukin-1 (IL-1) was investigated for its potential to image infectious foci in vivo in an animal model of infection. Twenty-four hours after induction of aStaphylococcus aureus abscess in the left calf muscle, mice were i.v. injected with both iodine-125 labelled IL-1 and iodine-131 labelled myoglobin, a size-matched control agent. The animals were killed for tissue biodistribution studies at 2, 6, 12, 24 and 48 h p.i. Gamma camera images were obtained at 6, 24 and 48 h after injecting mice with123I-IL-1. Radioiodinated IL-1 rapidly cleared from the body; after 12 h the abscess was the organ with the highest activity. The absolute abscess uptake of125I-IL-1 remained high compared to131I-myo-globin, resulting in significantly higher abscess-to-muscle ratios of125I-IL-1 compared to 1311-myoglobin. The ratios of125I-IL-1 reached the ultimate value of 44.4±10.8 at 48 h p.i., whereas the ratios of131I-myoglobin did not exceed 5.9±0.7. Gamma camera imaging revealed clearly visible abscesses. In conclusion, our results demonstrate specific retention of radioiodinated IL-1 in the abscess, presumably by interaction of IL-1 with its receptor on the inflammatory cells. The high target to-background ratios that were obtained over the course of time indicate that the IL-1 receptor may be a valuable target for the imaging of infectious foci.Keywords
This publication has 22 references indexed in Scilit:
- Structure of an interleukin-1.beta. mutant with reduced bioactivity shows multiple subtle changes in conformation that affect protein-protein recognitionBiochemistry, 1993
- Radioimmunoconjugates in the detection of infection and inflammationSeminars in Nuclear Medicine, 1993
- A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studiesNuclear Medicine Communications, 1992
- Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humansCytokine, 1992
- Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.Journal of Clinical Investigation, 1991
- 99Tcm-HMPAO labelled leucocytesNuclear Medicine Communications, 1988
- Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor.The Journal of Experimental Medicine, 1986
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949